MPO and endothelial dysfunction: In pursuit of suitable biomarkers to identify patients with CSVD and predict the underlying etiology, markers of endothelial dysfunction (ICAM1, VCAM1, CD62E, CD62P), markers of inflammation and neutrophil chemotaxis (myeloperoxidase (MPO) and calprotectin), and markers establishing the role of platelets (CXCL4 and 7) were included.